The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2026

Filed:

Apr. 24, 2020
Applicants:

President and Fellows of Harvard College, Cambridge, MA (US);

Ohio State Innovation Foundation, Columbus, OH (US);

Massachusetts Eye and Ear Infirmary, Boston, MA (US);

Inventors:

David P. Corey, Cambridge, MA (US);

Artur Indzhykulian, Boston, MA (US);

Marcos Sotomayor, Columbus, OH (US);

Maryna V. Ivanchenko, Cambridge, MA (US);

Cole W. D. Peters, Cambridge, MA (US);

Assignees:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C07K 14/705 (2006.01); C12N 15/90 (2006.01); A61K 48/00 (2006.01); C12N 15/113 (2010.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); C07K 14/705 (2013.01); C12N 15/90 (2013.01); A61K 48/005 (2013.01); C12N 15/1138 (2013.01); C12N 2310/20 (2017.05); C12N 2750/14143 (2013.01); C12Y 305/04004 (2013.01);
Abstract

Aspects of the disclosure relate to compositions, nucleic acids, vectors, viruses, and methods useful for treating hearing loss and/or blindness, for example, Usher Syndrome type IF. The present disclosure provides isolated nucleic acids, vectors, and rAAV.9.PHP.B comprising a transgene encoding a mini-PCDH15, and methods of treating hearing loss using the same. The present disclosure also provides a gRNA associated with a base editor to correct one or more mutations in PCDH15 for treating hearing loss and/or vision loss.


Find Patent Forward Citations

Loading…